Sale disclosed
David R. Brennan
Director
Common Stock
- Reported value
- $3.1M
- Reported price
- $124.00 / share
Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…
INSMED Inc
Last 30 daysNo qualifying insider buying. Sales: $3.1M by 1 insider.
Showing the first 6 of 20 trades on this page.
Director
Common Stock
Director
Common Stock
Chief Operating Officer
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chief Medical Officer
Common Stock
Chief Medical Officer
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chair and CEO
Common Stock
Chief Legal Officer
Common Stock
Chair and CEO
Common Stock
Chief Operating Officer
Common Stock
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Common StockSale | 25,000$124.00 / share | $3.1M | Sep 9Filed Sep 11 · 2d later | SEC filing |
| Director | Common StockSale | 5,000$127.53 / share | $637.65K | Aug 17Filed Aug 19 · 2d later | SEC filing |
| Chief Operating Officer | Common StockSale | 239,850$133.27 / share | $31.96M | Aug 10Filed Aug 12 · 2d later | SEC filing |
| Chief Medical Officer | Common StockSale10b5-12 trades | 27,173avg $128.61 / share | $3.49M | Aug 6Filed Aug 7 · 1d later | 2 filings
|
| Chair and CEO | Common StockSale10b5-12 trades | 10,700avg $106.06 / share | $1.13M | Jul 23Filed Jul 24 · 1d later | 2 filings
|
| Chair and CEO | Common StockSale10b5-13 trades | 10,699avg $117.40 / share | $1.26M | Jul 9Filed Jul 10 · 1d later | 3 filings
|
| Chief Medical Officer | Common StockSale10b5-12 trades | 12,302avg $109.98 / share | $1.35M | Jul 6Filed Jul 8 · 2d later | 2 filings
|
| Chair and CEO | Common StockSale10b5-15 trades | 21,398avg $103.32 / share | $2.21M | Jun 25Filed Jun 26 · 1d later | 5 filings
|
| Chief Legal Officer | Common StockSale10b5-1 | 1,806$95.82 / share | $173.05K | Jun 22Filed Jun 24 · 2d later | SEC filing |
| Chair and CEO | Common StockSale10b5-1 | 6,515$94.03 / share | $612.61K | Jun 8Filed Jun 10 · 2d later | SEC filing |
| Chief Operating Officer | Common StockSale | 2,370$102.27 / share | $242.38K | Jun 3Filed Jun 5 · 2d later | SEC filing |
Showing the latest 20 of 55 trades. Show all 55 trades
Insmed Incorporated - Common Stock (INSM) · Stock
The filing reports a partial sale for a joint account.
Josh GottheimerReporting House memberInsmed Incorporated - Common Stock (INSM) · Stock
The filing reports a sale for the member.
Gilbert CisnerosReporting House memberInsmed Incorporated - Common Stock (INSM) · Stock
The filing reports a partial sale for the member.
Gilbert CisnerosReporting House memberNo eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.